Clara cell protein CC16: A new lung epithelial biomarker for acute lung injury

Chest

Volumn 135, Issue 6, 2009, Pages 1408-1410

  McAuley, Danny F ^a   Matthay, Michael A ^b,c  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CLARA CELL PROTEIN; CLARA CELL PROTEIN 16; PROTEIN; PROTEIN RAGE; SURFACTANT PROTEIN D; UNCLASSIFIED DRUG;

ACUTE LUNG INJURY; ACUTE RESPIRATORY FAILURE; ARTIFICIAL VENTILATION; CLARA CELL; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; EDITORIAL; EPITHELIUM CELL; HUMAN; LUNG ALVEOLUS CELL TYPE 2; LUNG ALVEOLUS EPITHELIUM; LUNG FLUID; LUNG WEDGE PRESSURE; PATHOGENESIS; PLASMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TIDAL VOLUME;

EID: 66649132217     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.09-0304     Document Type: Editorial

References (14)

1. Matthay MA, Zimmerman GA. Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management. Am J Respir Cell Mol Biol 2005; 33:319-327 (Pubitemid 41416281)
2. Wang L, Bastarache JA, Wickersham N, et al. Novel role of human alveolar epithelium in regulating intra-alveolar coagulation. Am J Respir Cell Mol Biol 2007; 293:364-374
3. Ware LB, Matthay MA, Parsons PE, et al. Pathogenetic and prognostic significance of altered coagulation and fibrinolysis in acute lung injury/acute respiratory distress syndrome. Crit Care Med 2007; 35:1821-1828 (Pubitemid 47220354)
4. Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149:818-824 (Pubitemid 24082248)
5. Ware LB, Kaner RJ, Crystal RG, et al. VEGF levels in the alveolar compartment do not distinguish ARDS and pulmonary oedema. Eur Respir J 2005; 26:101-105 (Pubitemid 40945937)
6. ARDS Network. Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury. N Engl J Med 2006; 354:2213-2224 (Pubitemid 43788136)
7. Kropski JA, Fremont RD, Calfee CS, et al. Clara cell protein (CC16), a marker of lung epithelial injury, is decreased in plasma and pulmonary edema fluid from patients with acute lung injury. Chest 2009; 135:1440-1447
8. Uchida T, Shirasawa M, Ware LB, et al. Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury. Am J Respir Crit Care Med 2006; 173:1008-1015
9. Calfee CS, Ware LB, Eisner MD, et al. Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury. Thorax 2008; 63:1083-1089
10. Eisner MD, Parsons P, Matthay MA, et al. Plasma surfactant protein levels and clinical outcomes in patients with acute lung injury. Thorax 2003; 58:983-988 (Pubitemid 37392811)
11. Betsuyaku T, Fukuda Y, Parks WC, et al. Gelatinase B is required for alveolar bronchiolization after intratracheal bleomycin. Am J Pathol 2000; 157:525-535 (Pubitemid 30626912)
12. Frank JA, Gutierrez JA, Jones KD, et al. Low tidal volume reduces epithelial and endothelial injury in acid-injured rat lungs. Am J Respir Crit Care Med 2002; 165:242-249 (Pubitemid 34084465)
13. Bucher HC, Guyatt GH, Cook DJ, et al. Users' guides to the medical literature: XIX. Applying clinical trial results: a how to use an article measuring the effect of an intervention on surrogate end points; Evidence-Based Medicine Working Group. JAMA 1999; 282:771-778
14. McClintock D, Zhuo H, Wickersham N, et al. Biomarkers of inflammation, coagulation, and fibrinolysis predict mortality in acute lung injury. Crit Care 2008; 12:R41